The Medicines Company Revenue and Competitors
Estimated Revenue & Valuation
- The Medicines Company's estimated annual revenue is currently $300M per year.
- The Medicines Company's estimated revenue per employee is $887,574
- The Medicines Company's total funding is $70M.
Employee Data
- The Medicines Company has 338 Employees.
- The Medicines Company grew their employee count by 2% last year.
The Medicines Company's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Development Operations | Reveal Email/Phone |
2 | VP, Global Health Science Center | Reveal Email/Phone |
3 | EVP, Chief Financial Officer | Reveal Email/Phone |
4 | Director, Clinical Development | Reveal Email/Phone |
5 | Senior Director Compensation and Benefits | Reveal Email/Phone |
6 | Director, Global Health Science | Reveal Email/Phone |
7 | Manager | Reveal Email/Phone |
8 | Clinical Data Manager | Reveal Email/Phone |
9 | Senior Manager, Medical Information | Reveal Email/Phone |
10 | Global Heath Scientist | Reveal Email/Phone |
The Medicines Company Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is The Medicines Company?
The Medicines Company was founded in 1996 to acquire, develop and commercialize selected pharmaceutical products in late stages of development and approved products. ANGIOMAX is approved in the United States for use as an intravenous anticoagulant in combination with aspirin in patients with unstable angina undergoing coronary balloon angioplasty, and is expected to be the cornerstone product of a planned acute-care hospital franchise. The Company is also developing another intravenous agent, clevidipine, for the short-term control of high blood pressure in the hospital setting.
keywords:N/A
$70M
Total Funding
338
Number of Employees
$300M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
The Medicines Company News
Several generic companies (many of which are covered by the licensing agreement between the Medicines Pool and Pfizer) are in discussion...
And in November 2021before the FDA approved PaxlovidPfizer struck a sub-licensing deal with UN-backed Medicines Patent Pool to provide the...
A deal signed by the Medicines Patent Pool and Pfizer would allow ... WHO is encouraging transparency around what the company charges,...
Other Companies in East Hanover
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $169.1M | 501 | 12% | N/A |